Loading...
Uploaded by MedPageToday on Oct 20, 2009
PHILADELPHIA -- The investigational monoclonal antibody belimumab (Benlysta) was safe and effective for patients with systemic lupus erythematosus in a Phase III trial, researchers reported.
News & Politics
Standard YouTube License
Load more suggestions
Link to this comment:
All Comments (0)